260 related articles for article (PubMed ID: 25809144)
21. Steroid or calcineurin inhibitor-sparing immunosuppressive protocols.
Grinyó JM; Cruzado JM
Contrib Nephrol; 2005; 146():30-42. PubMed ID: 15567918
[TBL] [Abstract][Full Text] [Related]
22. Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation.
Jacquet A; Francois H; Frangie C; Ahmad L; Charpentier B; Durrbach A
Transpl Immunol; 2008 Nov; 20(1-2):29-31. PubMed ID: 18817870
[TBL] [Abstract][Full Text] [Related]
23. Can the early elimination of calcineurin inhibitors result in clinical benefits?
Weir MR
Transplant Proc; 2010 Nov; 42(9 Suppl):S16-20. PubMed ID: 21095444
[TBL] [Abstract][Full Text] [Related]
24. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
[TBL] [Abstract][Full Text] [Related]
25. Optimal immunosuppression to prevent chronic allograft dysfunction.
Grinyó JM; Bestard O; Torras J; Cruzado JM
Kidney Int Suppl; 2010 Dec; (119):S66-70. PubMed ID: 21116321
[TBL] [Abstract][Full Text] [Related]
26. Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation.
Wong TC; Lo CM; Fung JY
Expert Opin Emerg Drugs; 2017 Jun; 22(2):123-136. PubMed ID: 28503959
[TBL] [Abstract][Full Text] [Related]
27. Operational tolerance: past lessons and future prospects.
Levitsky J
Liver Transpl; 2011 Mar; 17(3):222-32. PubMed ID: 21384504
[TBL] [Abstract][Full Text] [Related]
28. Evolution of donor-specific antibodies (DSA) and incidence of de novo DSA in solid organ transplant recipients after switch to everolimus alone or associated with low dose of calcineurin inhibitors.
Perbos E; Juinier E; Guidicelli G; Dromer C; Merville P; Billes MA; Taupin JL; Neau-Cransac M
Clin Transplant; 2014 Sep; 28(9):1054-60. PubMed ID: 25040585
[TBL] [Abstract][Full Text] [Related]
29. Calcineurin inhibitor-free immunosuppression in kidney transplantation.
Guerra G; Srinivas TR; Meier-Kriesche HU
Transpl Int; 2007 Oct; 20(10):813-27. PubMed ID: 17645419
[TBL] [Abstract][Full Text] [Related]
30. Preventing renal transplant failure.
Vathsala A
Ann Acad Med Singap; 2005 Jan; 34(1):36-43. PubMed ID: 15726218
[TBL] [Abstract][Full Text] [Related]
31. [The mechanisms of chronic kidney damage in renal transplant and their possible reversibility].
Schena FP; Maiorano A; Rossini M
G Ital Nefrol; 2008; 25 Suppl 44():S11-4. PubMed ID: 19048580
[TBL] [Abstract][Full Text] [Related]
32. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
33. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes.
Baron D; Giral M; Brouard S
Transpl Int; 2015 Aug; 28(8):938-59. PubMed ID: 25851900
[TBL] [Abstract][Full Text] [Related]
34. An Update on Calcineurin Inhibitor-Free Regimens: The Need Persists, but the Landscape has Changed.
Webber AB; Vincenti F
Transplantation; 2016 Apr; 100(4):836-43. PubMed ID: 27003097
[TBL] [Abstract][Full Text] [Related]
35. The impact of calcineurin inhibitors on graft survival.
Rush D
Transplant Rev (Orlando); 2013 Jul; 27(3):93-5. PubMed ID: 23743217
[TBL] [Abstract][Full Text] [Related]
36. [Immunosuppression and treatment of graft rejection after kidney transplantation].
May G
Urologe A; 1994 Sep; 33(5):365-9. PubMed ID: 7974923
[TBL] [Abstract][Full Text] [Related]
37. Belatacept in Solid Organ Transplant: Review of Current Literature Across Transplant Types.
Perez CP; Patel N; Mardis CR; Meadows HB; Taber DJ; Pilch NA
Transplantation; 2018 Sep; 102(9):1440-1452. PubMed ID: 29787522
[TBL] [Abstract][Full Text] [Related]
38. Current concepts and perspectives of immunosuppression in organ transplantation.
Scherer MN; Banas B; Mantouvalou K; Schnitzbauer A; Obed A; Krämer BK; Schlitt HJ
Langenbecks Arch Surg; 2007 Sep; 392(5):511-23. PubMed ID: 17450373
[TBL] [Abstract][Full Text] [Related]
39. Kidney transplantation in HIV-positive patients treated with a steroid-free immunosuppressive regimen.
Bossini N; Sandrini S; Casari S; Tardanico R; Maffeis R; Setti G; Valerio F; Forleo MA; Nodari F; Cancarini G
Transpl Int; 2014 Oct; 27(10):1050-9. PubMed ID: 24964311
[TBL] [Abstract][Full Text] [Related]
40. Calcineurin Inhibitor Free De Novo Immunosuppression in Liver Transplant Recipients With Pretransplant Renal Impairment: Results of a Pilot Study (PATRON07).
Schnitzbauer AA; Sothmann J; Baier L; Bein T; Geissler EK; Scherer MN; Schlitt HJ
Transplantation; 2015 Dec; 99(12):2565-75. PubMed ID: 26018348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]